Correction to "Temozolomide, Gemcitabine, and Decitabine Hybrid Nanoconjugates: From Design to Proof-of-Concept (PoC) of Synergies toward the Understanding of Drug Impact on Human Glioblastoma Cells"

J Med Chem. 2022 Jul 14;65(13):9506. doi: 10.1021/acs.jmedchem.2c00892. Epub 2022 Jun 30.
No abstract available

Publication types

  • Published Erratum